Oktay AN - Search Results

1

Investigation of Flurbiprofen Pharmacokinetics in Rats Following Dermal Administration of Optimized Cyclodextrin-Based Nanogel.

Oktay AN, Celebi N, Ilbasmis-Tamer S. Oktay AN, et al. Eur J Pharm Sci. 2025 Jan 17:107021. doi: 10.1016/j.ejps.2025.107021. Online ahead of print. Eur J Pharm Sci. 2025. PMID: 39827972 Free article.

2

Screening of Polymers for Oral Ritonavir Amorphous Solid Dispersions by Film Casting.

Oktay AN, Polli JE. Oktay AN, et al. Pharmaceutics. 2024 Oct 26;16(11):1373. doi: 10.3390/pharmaceutics16111373. Pharmaceutics. 2024. PMID: 39598497 Free PMC article.

3

Evaluation of Pharmacokinetics of a BCS Class III Drug with Two Different Study Designs: Tenofovir Alafenamide Monofumarate Film-coated Tablet.

Arısoy M, Saydam M, Dolaksız YE, Demirbaş Ö, Talay Ç, Sağlam O, Demiray G, Kurtoğlu ED, Oktay AN. Arısoy M, et al. Among authors: oktay an. AAPS PharmSciTech. 2024 May 30;25(5):123. doi: 10.1208/s12249-024-02835-5. AAPS PharmSciTech. 2024. PMID: 38816624

4

Efficiency of single pharmaceutical surfactants to mimic intestinal biorelevant media solubilization and dissolution of etravirine: Comparison of intrinsic and film dissolution models.

Oktay AN, Polli JE. Oktay AN, et al. Eur J Pharm Sci. 2024 May 1;196:106746. doi: 10.1016/j.ejps.2024.106746. Epub 2024 Mar 16. Eur J Pharm Sci. 2024. PMID: 38499112 Free article.

5

Formulation Strategies of Nanosuspensions for Various Administration Routes.

Pınar SG, Oktay AN, Karaküçük AE, Çelebi N. Pınar SG, et al. Among authors: oktay an. Pharmaceutics. 2023 May 17;15(5):1520. doi: 10.3390/pharmaceutics15051520. Pharmaceutics. 2023. PMID: 37242763 Free PMC article. Review.

6

Enhanced Dermal Delivery of Flurbiprofen Nanosuspension Based Gel: Development and Ex Vivo Permeation, Pharmacokinetic Evaluations.

Oktay AN, Ilbasmis-Tamer S, Uludag O, Celebi N. Oktay AN, et al. Pharm Res. 2021 Jun;38(6):991-1009. doi: 10.1007/s11095-021-03060-6. Epub 2021 Jun 4. Pharm Res. 2021. PMID: 34086139

7

Etodolac nanosuspension based gel for enhanced dermal delivery: in vitro and in vivo evaluation.

Karakucuk A, Tort S, Han S, Oktay AN, Celebi N. Karakucuk A, et al. Among authors: oktay an. J Microencapsul. 2021 Jun;38(4):218-232. doi: 10.1080/02652048.2021.1895344. Epub 2021 Mar 23. J Microencapsul. 2021. PMID: 33752553

8

Preparation and in vitro / in vivo evaluation of flurbiprofen nanosuspension-based gel for dermal application.

Oktay AN, Ilbasmis-Tamer S, Han S, Uludag O, Celebi N. Oktay AN, et al. Eur J Pharm Sci. 2020 Dec 1;155:105548. doi: 10.1016/j.ejps.2020.105548. Epub 2020 Sep 13. Eur J Pharm Sci. 2020. PMID: 32937211

9

The effect of critical process parameters of the high pressure homogenization technique on the critical quality attributes of flurbiprofen nanosuspensions.

Oktay AN, Ilbasmis-Tamer S, Celebi N. Oktay AN, et al. Pharm Dev Technol. 2019 Dec;24(10):1278-1286. doi: 10.1080/10837450.2019.1667384. Pharm Dev Technol. 2019. PMID: 31535942

10

Dermal flurbiprofen nanosuspensions: Optimization with design of experiment approach and in vitro evaluation.

Oktay AN, Karakucuk A, Ilbasmis-Tamer S, Celebi N. Oktay AN, et al. Eur J Pharm Sci. 2018 Sep 15;122:254-263. doi: 10.1016/j.ejps.2018.07.009. Epub 2018 Jul 4. Eur J Pharm Sci. 2018. PMID: 29981401

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

11 results

Search Page

Filters